Influence of HLA polymorphism on persistent remission in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 61, Issue 4, 2002, Pages 351-353

  Molenaar, E T H ^a   Voskuyl, A E ^a   van der Hosrt Bruinsma, I E ^a   Schreuder, G M Th ^b   Zanelli, E ^b   Dijkmans, B A C ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; EPITOPE; GOLD; HLA DQ ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; PATHOGENESIS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; REMISSION INDUCTION;

EID: 0036206810     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.4.351     Document Type: Article

References (16)

1. Twin concordance rates for rheumatoid arthritis: Results from a nation wide study
2. Contribution of inherited factors to rheumatoid arthritis
3. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
4. HLA genes in rheumatoid arthritis; identification of susceptibility alleles using specific oligonucleotide probes
5. HLA-DRB1,-DQA1 and DQB1 genotypes and risk of vasculitis in patients with rheumatoid arthritis
6. HLA-DR1, DR4 and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a wide community based study
7. HLA class II association with rheumatoid arthritis. Facts and interpretations
8. HLA-DQ associated predisposition to dominant HLA-DR associated protection against rheumatoid arthritis
9. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis. HLA-DQ and -DR polymorphisms predict outcome in patients with early synovitis
10. An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition
11. Preliminary criteria for clinical remission in rheumatoid arthritis
12. Judging disease activity in clinical practice in rheumatoid arthritis; a first step in the development of a disease activity score
13. Biotinylated DRB sequence specific oligonucleotides: Comparison to serologic HLA-DR typing of organ donors in Eurotransplant
14. Diversity in HLA-DR4-related DR, DQ haplotypes in Australia, Oceania, and China
15. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in two hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
16. The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis